0000891293-15-000037.txt : 20150925
0000891293-15-000037.hdr.sgml : 20150925
20150925164232
ACCESSION NUMBER: 0000891293-15-000037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150924
FILED AS OF DATE: 20150925
DATE AS OF CHANGE: 20150925
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI BIOPHARMA CORP
CENTRAL INDEX KEY: 0000891293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911533912
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 2062827100
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 19960321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Plunkett Matthew
CENTRAL INDEX KEY: 0001557551
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12465
FILM NUMBER: 151125555
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE, SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-09-24
0
0000891293
CTI BIOPHARMA CORP
ctic
0001557551
Plunkett Matthew
3101 WESTERN AVENUE, SUITE 600
SEATTLE
WA
98121
0
1
0
0
EVP, Corporate Development
Common Stock
2015-09-24
4
S
0
3600
1.52
D
797353
D
Common Stock
2015-09-24
4
S
0
13201
1.525
D
784152
D
Common Stock
2015-09-24
4
S
0
200
1.5275
D
783952
D
Common Stock
2015-09-24
4
S
0
6899
1.53
D
777053
D
Common Stock
2015-09-24
4
S
0
100
1.535
D
776953
D
Common Stock
2015-09-24
4
S
0
289
1.54
D
776664
D
Common Stock
2015-09-24
4
S
0
600
1.545
D
776064
D
Common Stock
2015-09-24
4
S
0
800
1.55
D
775264
D
Common Stock
2015-09-24
4
S
0
800
1.56
D
774464
D
Common Stock
2015-09-24
4
S
0
1700
1.57
D
772764
D
Common Stock
2015-09-24
4
S
0
1000
1.575
D
771764
D
Common Stock
2015-09-24
4
S
0
5330
1.58
D
766434
D
Common Stock
2015-09-24
4
S
0
7000
1.585
D
759434
D
Common Stock
2015-09-24
4
S
0
16400
1.59
D
743034
D
Common Stock
2015-09-24
4
S
0
1500
1.595
D
741534
D
Common Stock
2015-09-24
4
S
0
14400
1.6
D
727134
D
Common Stock
2015-09-24
4
S
0
1390
1.605
D
725744
D
Common Stock
2015-09-24
4
S
0
660
1.61
D
725084
D
The sale was effected pursuant to a Rule 10b5-1 trading plan.
By: Louis A. Bianco, Attorney-in-fact For: Matthew Plunkett
2015-09-25